###begin article-title 0
###xml 89 97 89 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vitro</italic>
###xml 102 109 102 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In Vivo</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Telomerase Reverse Transcriptase (hTERT) Q169 Is Essential for Telomerase Function In Vitro and In Vivo
###end article-title 0
###begin p 1
Conceived and designed the experiments: HDW TB. Performed the experiments: HDW ART DAL. Analyzed the data: HDW TB. Contributed reagents/materials/analysis tools: TB. Wrote the paper: HDW.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Telomerase is a reverse transcriptase that maintains the telomeres of linear chromosomes and preserves genomic integrity. The core components are a catalytic protein subunit, the telomerase reverse transcriptase (TERT), and an RNA subunit, the telomerase RNA (TR). Telomerase is unique in its ability to catalyze processive DNA synthesis, which is facilitated by telomere-specific DNA-binding domains in TERT called anchor sites. A conserved glutamine residue in the TERT N-terminus is important for anchor site interactions in lower eukaryotes. The significance of this residue in higher eukaryotes, however, has not been investigated.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 299 307 299 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 312 319 312 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 111 116 <span type="species:ncbi:9606">human</span>
To understand the significance of this residue in higher eukaryotes, we performed site-directed mutagenesis on human TERT (hTERT) Q169 to create neutral (Q169A), conservative (Q169N), and non-conservative (Q169D) mutant proteins. We show that these mutations severely compromise telomerase activity in vitro and in vivo. The functional defects are not due to abrogated interactions with hTR or telomeric ssDNA. However, substitution of hTERT Q169 dramatically impaired the ability of telomerase to incorporate nucleotides at the second position of the template. Furthermore, Q169 mutagenesis altered the relative strength of hTERT-telomeric ssDNA interactions, which identifies Q169 as a novel residue in hTERT required for optimal primer binding. Proteolysis experiments indicate that Q169 substitution alters the protease-sensitivity of the hTERT N-terminus, indicating that a conformational change in this region of hTERT is likely critical for catalytic function.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 406 411 <span type="species:ncbi:9606">human</span>
We provide the first detailed evidence regarding the biochemical and cellular roles of an evolutionarily-conserved Gln residue in higher eukaryotes. Collectively, our results indicate that Q169 is needed to maintain the hTERT N-terminus in a conformation that is necessary for optimal enzyme-primer interactions and nucleotide incorporation. We show that Q169 is critical for the structure and function of human telomerase, thereby identifying a novel residue in hTERT that may be amenable to therapeutic intervention.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 258 261 258 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Bailey1">[1]</xref>
###xml 263 266 263 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Palm1">[2]</xref>
###xml 392 395 392 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Stewart1">[3]</xref>
###xml 743 746 743 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Olovnikov1">[4]</xref>
###xml 748 751 748 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Watson1">[5]</xref>
###xml 753 756 753 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Olovnikov2">[6]</xref>
###xml 758 761 758 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Harley1">[7]</xref>
###xml 1074 1077 1074 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Greider1">[8]</xref>
###xml 1079 1082 1079 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Greider2">[9]</xref>
###xml 1084 1088 1084 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Greider3">[10]</xref>
###xml 1210 1217 1210 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1245 1253 1245 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1267 1271 1267 1271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Autexier1">[11]</xref>
###xml 1273 1277 1273 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Theimer1">[12]</xref>
###xml 1367 1371 1367 1371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Autexier1">[11]</xref>
###xml 1391 1399 1391 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g001">Figure 1</xref>
###xml 1715 1719 1715 1719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Autexier1">[11]</xref>
###xml 1721 1725 1721 1725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Kelleher1">[13]</xref>
###xml 1860 1864 1860 1864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Autexier1">[11]</xref>
###xml 421 426 <span type="species:ncbi:9606">human</span>
Telomeres are DNA-protein structures that define the ends of linear chromosomes and form a protective 'cap' that enables cells to maintain chromosome length and stability by preventing telomere degradation, recombination, and end-to-end fusions (reviewed in [1], [2]). The proper maintenance of telomere structure and function is crucial for prolonged cell proliferation and genome stability [3]. Indeed, one hallmark of human cancer cells is the up-regulation of telomere maintenance mechanisms that prevent telomere shortening and confer unlimited replicative capacity. In normal cells, however, the inability of conventional DNA polymerases to fully replicate the ends of linear chromosomes results in telomere erosion during cell division [4], [5], [6], [7]. Most eukaryotes utilize an enzyme called telomerase to synthesize and maintain telomeric DNA. Telomerase is a ribonucleoprotein (RNP) reverse transcriptase (RT) complex that minimally contains a catalytic protein subunit, the telomerase reverse transcriptase (TERT), and an RNA subunit, the telomerase RNA (TR) [8], [9], [10]. TERT uses a small RNA template within TR to reverse transcribe telomeric nucleotides onto the ss 3'-ends of chromosomes in vivo or G-rich oligonucleotides in vitro (reviewed in [11], [12]). TERT proteins are structurally defined by conserved RT and telomerase-specific domains [11]. As illustrated in Figure 1, the structural organization of TERT can be divided into at least three modular regions: 1) a long N-terminal extension (NTE) that contains conserved domains and an unstructured linker region, 2) a central catalytic RT domain with seven evolutionarily-conserved RT motifs, and 3) a short C-terminal extension (CTE) [11], [13]. TERT-specific domains in the NTE and CTE contribute to the biochemical properties that distinguish telomerase from prototypical RT's [11].
###end p 9
###begin title 10
Linear representation of hTERT.
###end title 10
###begin p 11
The conserved catalytic reverse transcriptase (RT) domain is depicted with a light grey box, the black box represents the conserved telomerase-specific (TS) motif, white boxes depict the N- and RT-primer grip regions and the black circle signifies the approximate location of Q169. The schematics below indicate the predicted locations of RNA-interacting domains 1 and 2 (RID 1 and RID 2, respectively) and the TERT essential N-terminal (TEN) domain. NTE: N-terminal extension and CTE: C-terminal extension.
###end p 11
###begin p 12
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Garcia1">[14]</xref>
###xml 490 497 490 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 83 88 <span type="species:ncbi:9606">human</span>
###xml 258 263 <span type="species:ncbi:9606">human</span>
###xml 642 647 <span type="species:ncbi:9606">human</span>
###xml 718 723 <span type="species:ncbi:9606">human</span>
Genetic and somatic mutations that disrupt the normal assembly and function of the human telomerase RNP are associated with a spectrum of disease states [14]. The physiological importance of telomerase is further illustrated by the fact that at least 85% of human cancers exhibit up-regulated telomerase activity, which prevents telomere shortening and confers these cells with unlimited replicative capacity. This emphasizes the need for therapeutics that can modulate telomerase activity in vivo. Unfortunately, the applicability of current therapies is limited because the molecular mechanism(s) that regulate the assembly and activity of human telomerase are poorly understood. Thus, structure-function studies of human telomerase are necessary for the rationale design of novel telomerase inhibitors.
###end p 12
###begin p 13
###xml 135 139 135 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Weinrich1">[15]</xref>
###xml 141 145 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Beattie1">[16]</xref>
###xml 239 246 239 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Holt1">[17]</xref>
###xml 252 256 252 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Forsythe1">[18]</xref>
###xml 258 262 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Cohen1">[19]</xref>
###xml 264 268 264 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Venteicher1">[20]</xref>
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Venteicher2">[21]</xref>
###xml 400 403 400 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Greider1">[8]</xref>
###xml 405 409 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Morin1">[22]</xref>
###xml 411 415 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Greider4">[23]</xref>
###xml 820 824 820 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Autexier1">[11]</xref>
###xml 1124 1128 1124 1128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Harrington1">[24]</xref>
###xml 1130 1134 1130 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Lee1">[27]</xref>
###xml 1357 1361 1357 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Autexier1">[11]</xref>
###xml 11 16 <span type="species:ncbi:9606">human</span>
###xml 52 58 <span type="species:ncbi:9986">rabbit</span>
###xml 103 108 <span type="species:ncbi:9606">human</span>
Functional human telomerase can be reconstituted in rabbit reticulocyte lysates (RRL) by co-expressing human TERT (hTERT) and TR (hTR) [15], [16], although additional proteins are required for telomerase assembly, activity, and regulation in vivo[17], [18], [19], [20], [21]. A unique attribute of telomerase is its ability to processively synthesize telomeric repeats (repeat addition processivity) [8], [22], [23]. Telomerase recognizes, binds, and correctly orientates the telomeric DNA primer in the active site to initiate reverse transcription. TERT subsequently copies the TR template, one nucleotide (nt) at a time, until reaching the template 5'-boundary region. At this point, the position of the RT active site relative to the nascent DNA 3'-end must be reset to initiate the next round of telomere synthesis [11]. An important requisite of processive repeat synthesis is that telomerase remains bound to the telomere during the entire reaction cycle. TERT contains template-independent DNA-binding regions outside the RT domain, known as anchor sites, that interact with primer nt upstream of the RNA-DNA hybrid [24], [27]. Anchor site interactions are thought to confer repeat addition processivity by anchoring telomerase to the telomere and preventing dissociation during translocation when the RNA-DNA hybrid in the active site is separated [11].
###end p 13
###begin p 14
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Autexier1">[11]</xref>
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Wyatt1">[28]</xref>
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Finger1">[29]</xref>
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Romi1">[30]</xref>
###xml 149 153 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Lue1">[31]</xref>
###xml 155 159 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Zaug1">[32]</xref>
###xml 202 213 202 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tetrahymena</italic>
###xml 328 332 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Jacobs1">[33]</xref>
###xml 453 457 453 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Jacobs1">[33]</xref>
###xml 507 518 507 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tetrahymena</italic>
###xml 565 569 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Romi1">[30]</xref>
###xml 571 575 571 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Jacobs1">[33]</xref>
###xml 789 797 789 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 797 801 797 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Romi1">[30]</xref>
###xml 803 807 803 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Jacobs1">[33]</xref>
###xml 863 887 863 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 989 996 989 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 996 1000 996 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Lue1">[31]</xref>
###xml 1145 1149 1145 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Romi1">[30]</xref>
###xml 1151 1155 1151 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Jacobs1">[33]</xref>
###xml 107 112 <span type="species:ncbi:4932">yeast</span>
###xml 118 124 <span type="species:ncbi:9606">humans</span>
###xml 863 887 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
A telomerase anchor region has been physically and functionally mapped to the TERT N-terminus in ciliates, yeast, and humans [11], [28], [29], [30], [31], [32]. The structure of an N-terminal domain of Tetrahymena TERT, known as the conserved TERT essential N-terminal (TEN) domain, has been determined by X-ray crystallography [33]. Conserved residues on the surface of this domain are predicted to form a previously unrecognized ssDNA-binding channel [33]. Photo-cross-linking studies have shown that the Tetrahymena TERT (tTERT) TEN domain binds telomeric ssDNA [30], [33]. Mutagenesis of key residues thought to be involved in ssDNA-binding, such as an invariant Gln (Q168 in tTERT), significantly reduced the interaction between tTERT and telomeric ssDNA and impaired enzyme activity in vitro[30], [33]. Furthermore, mutation of the corresponding residue in Saccharomyces cerevisiae TERT (Est2p Q146A) severely impaired telomerase activity and caused growth defects and telomere loss in vivo[31]. It is thought that this Gln is important for telomeric primer recognition and orientation in the catalytic site to initiate telomere synthesis [30], [33]. The contribution of this residue to telomerase structure and function in higher eukaryotes, however, has not been investigated.
###end p 14
###begin p 15
###xml 461 469 461 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 525 532 525 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 190 195 <span type="species:ncbi:9606">human</span>
###xml 345 350 <span type="species:ncbi:9606">Human</span>
###xml 598 603 <span type="species:ncbi:9606">human</span>
###xml 1290 1295 <span type="species:ncbi:9606">human</span>
In this study, we aimed to determine if the evolutionarily-conserved Gln was important for telomerase function in higher eukaryotes and therefore, characterized the corresponding residue in human TERT (Q169). Site-directed mutagenesis was used to create neutral (Q169A), conservative (Q169N), and non-conservative (Q169D) mutant hTERT proteins. Human telomerase reconstituted with hTERT Q169A, Q169D, or Q169N exhibited severely reduced levels of DNA synthesis in vitro and hTERT Q169A failed to catalyze telomere elongation in vivo. Substitution of hTERT Q169 dramatically impaired the ability of human telomerase to incorporate nucleotides at the second position of the template. Mutation of Q169 did not abrogate the ability of hTERT to interact with hTR or telomeric ssDNA. When compared to wild type hTERT, however, the Q169 mutants exhibited subtle differences in the relative strength of the interaction with telomeric ssDNA, thereby elucidating a role for Q169 in protein-DNA interactions. Limited proteolysis experiments indicate that the Q169 substitutions altered the protease-sensitivity of the hTERT N-terminus, revealing the importance of conformational changes in this region of hTERT for enzyme activity. We show that the conserved Gln is a functionally critical residue in human telomerase and provide the first detailed evidence regarding the biochemical and cellular significance of this residue in higher eukaryotes.
###end p 15
###begin title 16
Materials and Methods
###end title 16
###begin title 17
Oligonucleotides
###end title 17
###begin p 18
###xml 171 178 171 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007176-t001">Table 1</xref>
All oligonucleotides were synthesized by University Core DNA Services (University of Calgary, Calgary, AB). The oligonucleotide sequences, written 5' to 3', are listed in Table 1. Unless otherwise noted, the oligonucleotides used in the primer binding and conventional telomerase activity assays contain biotin at the 5'-end. The oligonucleotides used in the telomere repeat amplification protocol and terminal restriction fragment analysis do not contain biotin tags.
###end p 18
###begin title 19
Description of the ssDNA primers used in the primer binding and conventional telomerase activity assays.
###end title 19
###begin p 20
Primer, oligonucleotide name; Length, number of nucleotides; Biotin, whether the primer is 5'-biotinylated; Sequence, the 5' to 3' nucleotide sequence.
###end p 20
###begin title 21
hTERT constructs
###end title 21
###begin p 22
###xml 101 104 101 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 236 239 236 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 242 245 242 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sal</italic>
###xml 278 286 278 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 302 304 302 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
hTERT constructs were cloned using site-directed mutagenesis. Each construct contained an N-terminal EcoRI restriction site and FLAG epitope, and a C-terminal SalI restriction site. The identity of each hTERT construct was confirmed by EcoRI-SalI digestion, DNA sequencing, and in vitro expression of [35S]cysteine-labelled hTERT.
###end p 22
###begin title 23
Synthesis and purification of hTR
###end title 23
###begin p 24
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Beattie2">[34]</xref>
###xml 116 124 116 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 223 227 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Wyatt1">[28]</xref>
###xml 16 21 <span type="species:ncbi:9606">human</span>
The full length human telomerase RNA spanning nt 1 to 451, was cloned as described previously [34], and synthesized in vitro using the MEGAscript T7 transcription kit (Ambion, Cedarlane(R) Laboratories Ltd.) as detailed in [28].
###end p 24
###begin title 25
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 27 32 <span type="species:ncbi:9606">human</span>
In vitro reconstitution of human telomerase
###end title 25
###begin p 26
###xml 55 59 55 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Wyatt1">[28]</xref>
###xml 61 65 61 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Beattie2">[34]</xref>
###xml 102 110 102 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 156 159 156 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 376 384 370 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 67 72 <span type="species:ncbi:9606">Human</span>
###xml 120 126 <span type="species:ncbi:9986">rabbit</span>
hTR was cloned and synthesized as described previously [28], [34]. Human telomerase was reconstituted in vitro with the rabbit reticulocyte lysate (RRL) TNT(R) T7 Transcription-Translation System (Promega, Fisher Scientific Ltd.), according to the manufacturer's instructions. Final reaction volumes containing the appropriate hTERT plasmid DNA (10 ng/microL) and full length in vitro-transcribed hTR (10 ng/microL) were incubated at 30degreesC for 90 or 120 min.
###end p 26
###begin title 27
Cell lines and culture conditions
###end title 27
###begin p 28
###xml 126 129 126 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 0 29 <span type="species:ncbi:11723">Simian immunodeficiency virus</span>
###xml 34 38 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 68 73 <span type="species:ncbi:9606">human</span>
###xml 212 218 <span type="species:ncbi:9913">bovine</span>
Simian immunodeficiency virus 40 (SV40) large T-antigen transformed human embryonic kidney cells (293T) were cultured in GIBCO(R) high glucose Dulbecco's Modified Eagle's Media (DMEM) supplemented with 10% fetal bovine serum, 50 U/mL penicillin G, and 50 microg/mL streptomycin sulfate (Invitrogen). 1 microg/mL puromycin (Sigma-Aldrich) was added to the growth media for stable 293T cell lines. 293T cells were continuously passaged at 1:5 or 1:6.
###end p 28
###begin p 29
###xml 8 13 <span type="species:ncbi:9606">human</span>
###xml 198 204 <span type="species:ncbi:9913">bovine</span>
Primary human foreskin fibroblasts (BJ cells) were cultured in Lonza BioWhittaker* Minimum Essential Medium Eagle (EMEM) with EBSS (Fischer Scientific Ltd.) supplemented with L-glutamine, 10% fetal bovine serum, 50 U/mL penicillin G, and 50 microg/mL streptomycin sulfate (Invitrogen). Stable cell lines were cultured in media containing 0.1-0.5 microg/mL puromycin (Sigma-Aldrich). BJ cells were passaged at 1:4 or 1:5 until the culture divided 2.5 times more than the vector control cells or until the culture had exhausted its replicative potential. This stage was defined as the period when cultures failed to become confluent within 30 days and stained positive for beta-galactosidase at pH 6.0.
###end p 29
###begin title 30
Cell transfections and retroviral infections
###end title 30
###begin p 31
###xml 57 61 53 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">puro</sub>
###xml 68 72 64 68 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">puro</sub>
###xml 96 100 92 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">puro</sub>
293T cells were stably transfected with 1 microg of pBABEpuro, pBABEpuro-FLAG-hTERT WT, or pBABEpuro-FLAG-hTERT Q169A DNA using FuGENE transfection reagent (Roche). Transfected cultures were split into selective media containing 1.0 microg/mL puromycin (Sigma-Aldrich) 48 h post-transfection. The first plate to reach confluence under selection was arbitrarily defined as mean population doubling (mpd) 0.
###end p 31
###begin p 32
###xml 97 101 97 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">puro</sub>
###xml 108 112 108 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">puro</sub>
###xml 136 140 136 140 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">puro</sub>
###xml 266 270 266 270 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">puro</sub>
###xml 277 281 277 281 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">puro</sub>
###xml 305 309 305 309 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">puro</sub>
Retroviral infections were used to establish polyclonal BJ cell lines that stably expressed pBABEpuro, pBABEpuro-FLAG-hTERT WT, or pBABEpuro-FLAG-hTERT Q169A. 293T cells were used to package amphotropic retroviruses created with the helper plasmid pCL-10A1 and pBABEpuro, pBABEpuro-FLAG-hTERT WT, or pBABEpuro-FLAG-hTERT Q169A plasmid DNA. 293T cells were transiently transfected with the appropriate construct DNA using FuGENE transfection reagent (Roche). The viral supernatant was collected 24 h after transfection, filtered, supplemented with polybrene (Sigma-Aldrich) to a final concentration of 8 microg/mL, and applied to BJ cells. 48 h after retroviral infection, BJ cells were split 1:4 with selective media containing 0.1-0.5 microg/mL puromycin (Sigma-Aldrich). Mean population doubling 0 was arbitrarily defined as the time point when the infected cells reached 80-90% confluency in selective growth media.
###end p 32
###begin title 33
Cell lysis
###end title 33
###begin p 34
###xml 135 136 135 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Cell pellets were lysed in NP-40 lysis buffer (10 mM Tris-HCl, pH 7.5; 1% [vol/vol] NP-40; 10% [vol/vol] glycerol; 1 mM EGTA; 1 mM MgCl2; 150 mM NaCl) supplemented with fresh 5 mM beta-mercaptoethanol, 10 U/mL RNase Out (Invitrogen), and complete EDTA-free proteinase inhibitor cocktail tablet (Roche) on ice for 30 min followed by rocking at 4degreesC for an additional 30 min. Cell lysates were centrifuged at 12 100 x g for 30 min at 4degreesC to remove the insoluble debris. The soluble fraction was incubated with pre-equilibrated Protein G Sepharosetrade mark (GE Healthcare) for 30 min at 4degreesC with rocking and then centrifuged at 604 x g for 3 min at 4degreesC. Protein concentration in the pre-cleared soluble fraction was determined using the Bio-Rad Protein Detection Assay (Bio-Rad).
###end p 34
###begin title 35
Immunoprecipitations
###end title 35
###begin p 36
###xml 232 233 228 229 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
FLAG-hTERT was immunoprecipitated from soluble cell lysate (800-1000 microg) with anti-FLAG M2 affinity resin (Sigma-Aldrich) in IP buffer 150 (10 mM Tris-HCl, pH 7.5; 1% [vol/vol] NP-40; 10% [vol/vol] glycerol; 1 mM EGTA; 1 mM MgCl2; 150 mM NaCl) containing 10 U/mL RNase Out (Invitrogen) and EDTA-free proteinase inhibitor cocktail (Roche) for 2 h at 4degreesC with rocking. The protein-bead complexes were washed four times with either 1 mL of IP buffer 150 (washes 1 and 4) or IP buffer 300 (IP buffer containing 300 mM NaCl; washes 2 and 3). FLAG-hTERT was eluted from the affinity resin by two rounds of competitive elution with excess 3x FLAG peptide (Sigma-Aldrich); beads were resuspended in 30 microL IP 150 buffer containing 2 mg/mL 3x FLAG peptide, rocked for 30 min at 4degreesC, and then centrifuged at 604 x g for 3 min (4degreesC).
###end p 36
###begin title 37
Western analysis
###end title 37
###begin p 38
###xml 666 670 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Venteicher1">[20]</xref>
###xml 981 987 <span type="species:ncbi:9986">rabbit</span>
###xml 1004 1015 <span type="species:ncbi:3704">horseradish</span>
###xml 1040 1046 <span type="species:ncbi:9793">donkey</span>
hTERT protein expression was analyzed in immunoprecipitates from 293T and BJ cells. SDS-PAGE sample buffer was mixed with 30 microL of 3 x FLAG peptide eluate and the samples were boiled for 5 min and resolved by 8% SDS-PAGE. The gel was transferred to a polyvinylidene diflouride membrane in transfer buffer (25 mM Tris base; 190 mM glycine; 20% [vol/vol] methanol; pH adjusted to 8.0), fixed in methanol, air dried, and blocked with TBS (50 mM Tris-HCl, pH 7.4; 150 mM NaCl) containing 0.5% Tween-20 and 5% (wt/vol) nonfat dry milk (NFDM) for 1-2 h at RT. To detect hTERT, blocked membranes were probed with a 1:1000 dilution of the polyclonal anti-hTERT antibody [20] (a generous gift from Dr. S. Artandi, Stanford School of Medicine, Stanford, CA) prepared in TBST (TBS; 0.1% Tween-20) containing 2.5% (wt/vol) NFDM overnight at 4degreesC with gentle rocking. Blots were washed three times for 15-20 min each in TBST at RT, rinsed in TBS, and incubated with ECLtrade mark anti-rabbit immunoglobin G, horseradish peroxidase linked (from donkey) secondary antibody (GE Healthcare) (1:2000 dilution in TBST-2.5% [wt/vol] NFDM) for 1 h at RT. The blots were subsequently washed three times (10-15 min at RT) in TBST and once in TBS (5-10 min). Proteins were detected with enhanced chemiluminescence (ECL) reagent (GE Healthcare), according to the manufacturer's instructions.
###end p 38
###begin title 39
hTERT-hTR coimmunoprecipitation
###end title 39
###begin p 40
###xml 28 31 28 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 79 81 75 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 195 198 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 418 421 412 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 507 509 499 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 594 596 586 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 804 808 790 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Moriarty1">[35]</xref>
###xml 366 371 <span type="species:ncbi:9606">Human</span>
hTR was transcribed from an EcoRI-linearized plasmid in the presence of [alpha-32P]UTP (3000 Ci/mmol; 10 mCi/mL; GE Healthcare) with the MEGAscript T7-coupled expression system (Ambion, Cedarlane(R) Laboratories Ltd.), according to the manufacturer's instructions. Unincorporated nucleotides were removed using G-25 gel filtration microspin columns (GE Healthcare). Human telomerase was reconstituted using the RRL TNT(R) T7 Transcription-Translation System (Promega, Fisher Scientific Ltd.) with 30 ng/uL [32P]UTP-labelled hTR, 60 ng/uL FLAG-hTERT WT, Q169A, Q169D, or Q169N plasmid DNA, and [35S]cysteine (>1000 Ci/mmol, 10 mCi/mL; GE Healthcare). RRL reactions were incubated at 30degreesC for 60-90 min. hTERT-hTR complexes were immunoprecipitated using a method similar to that described previously [35].
###end p 40
###begin title 41
Limited proteolysis
###end title 41
###begin p 42
###xml 232 233 228 229 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 299 301 295 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 568 570 554 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 24 30 <span type="species:ncbi:9913">bovine</span>
alpha-chymotrypsin from bovine pancreas (Sigma-Aldrich) was reconstituted in 1 mM HCl containing 2 mM CaCl and diluted to the appropriate working concentration in 1x reaction buffer (10x stock  = 200 mM Tris-HCl, pH 8.3; 150 mM MgCl2; 630 mM KCl; 0.5% Tween-20; 10 mM EGTA, pH 8.0). RRL containing [35S]cysteine-labelled full length or 1-300 FLAG-hTERT WT, Q169A, Q169D, or Q169N was digested for 2 min at 30degreesC in 1x reaction buffer containing 10, 100, or 1000 ng/mL chymotrypsin (Sigma-Aldrich). 15 microL proteolysis reactions contained comparable amounts of [35S]cysteine-labelled hTERT. Reactions were terminated by the addition of SDS-PAGE loading buffer and boiling (5 min). Following digestion, products were resolved by 12% SDS-PAGE and visualized by autoradiography and phosphorimaging.
###end p 42
###begin title 43
Telomere repeat amplification protocol
###end title 43
###begin p 44
###xml 122 126 122 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Kim1">[36]</xref>
###xml 356 357 344 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 464 488 448 472 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AATCCGTCGAGCAGAGTT-3&#8242;</named-content>
###xml 502 505 486 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 614 615 594 595 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 597 624 577 604 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCGCGG[CTTACC]<sub>3</sub>CTAACC-3&#8242;</named-content>
###xml 649 651 621 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
Telomerase activity was detected using a modified, two-step version of the telomeric repeat amplification protocol (TRAP) [36]. In the first step (telomere extension), 1 microL of RRL or 2 microL of 3 x FLAG peptide eluate was incubated for 30 min at RT in a 50 microL volume containing 1x reaction buffer (10x stock  = 200 mM Tris-HCl, pH 8.3; 150 mM MgCl2; 630 mM KCl; 0.5% Tween-20; 10 mM EGTA, pH 8.0), 2.5 mM dATP, dCTP, dGTP, and dTTP, 0.1 microg TS primer (5'-AATCCGTCGAGCAGAGTT-3'), and 2 U of Taq DNA polymerase (Invitrogen). In the second step (amplification), 0.1 microg of ACX primer (5'-GCGCGG[CTTACC]3CTAACC-3') and 1 microL of [alpha-32P]dGTP (3000 Ci/mmol; 10 mCi/mL; GE Healthcare) was added to each 50 microL extension reaction, which was subsequently PCR-amplified for 20-25 cycles consisting of 95degreesC for 30 s, 50degreesC for 30 s, and 72degreesC for 90 s. TRAP reaction products (9 microL) were electrophoresed on a nondenaturing 12% (wt/vol) polyacrylamide gel (29:1 [wt/wt] acrylamide-bisacrylamide) and detected by autoradiography or exposure to a phosphorimaging screen.
###end p 44
###begin title 45
Conventional telomerase activity assay
###end title 45
###begin p 46
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Wyatt1">[28]</xref>
###xml 458 459 454 455 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 540 541 529 530 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 610 612 587 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 757 763 724 730 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TTAGGG</named-content>
###xml 764 765 731 732 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1052 1056 1013 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Wyatt1">[28]</xref>
###xml 85 90 <span type="species:ncbi:9606">human</span>
###xml 174 179 <span type="species:ncbi:9606">human</span>
The conventional telomerase activity (CTA) assay was used to measure the activity of human telomerase reconstituted in RRL, as described previously [28]. The processivity of human telomerase was determined with pulse-chase conventional telomerase activity (CTA) assays. In these experiments, RRL containing reconstituted telomerase was incubated in a 40 microL reaction containing 1x CTA buffer (10 x stock  = 500 mM Tris-HCl, pH 8.3; 500 mM KOAc; 10 mM MgCl2; 50 mM beta-mercaptoethanol; 10 mM spermidine), 1.5 microM biotinylated (TTAGGG)3 primer, 1 mM dATP, 1 mM dTTP, 1.25 microM dGTP, and 6 microL [alpha-32P]dGTP (3000 Ci/mmol, 10 mCi/mL; GE Healthcare) at 30degreesC for 5 min (pulse). The pulse reaction was chased with 200 microM non-biotinylated (TTAGGG)3 primer for 5, 15, or 30 min (chase) and terminated by incubating with stop buffer (10 mM EDTA; 2 M NaCl; 0.1 mg/mL RNase A) at 37degreesC for 15 min. Elongated biotinylated pulse primers were separated from elongated non-biotinylated chase primers using the method described previously [28].
###end p 46
###begin p 47
###xml 214 217 214 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 420 421 418 419 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 457 458 455 456 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 465 466 463 464 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 470 473 468 471 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i+1</sub>
###xml 489 492 479 482 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i+5</sub>
###xml 615 616 605 606 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 628 631 610 613 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i+5</sub>
###xml 861 864 841 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 1014 1019 <span type="species:ncbi:9606">human</span>
Telomerase activity was measured using data collected with the standard CTA assay and processivity was calculated with the data obtained in pulse-chase CTA experiments. Using phosphoimager analysis and Quantity One(R) version 4.5.0 software (Bio-Rad), the signal of each elongation product was quantified and normalized to the total number of labeled dGTP incorporated. Telomerase activity within one hexameric repeat (Pi) was calculated using the formula Pi  =  (Ti + Ti+1 + em leader + Ti+5). T values correspond to the signal of the elongation product at position i. The normalized values obtained at positions Ti em leader Ti+5 in each independent experiment were added and expressed as a fraction of WT telomerase activity. The mean activity was determined from three independent experiments and the results are reported+/-SEM. GraphPad InStat version 3.00(R) (GraphPad Software) was used to calculate Student's two-tailed unpaired T-tests and determine if total DNA synthesis was statistically different for human telomerase reconstituted with hTERT WT versus Q169A, Q169D, or Q169N.
###end p 47
###begin p 48
###xml 31 32 31 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 101 105 101 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Hardy1">[37]</xref>
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Huard1">[38]</xref>
###xml 224 225 224 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 232 235 232 235 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i+6</sub>
###xml 239 240 239 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 244 247 244 247 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i+6</sub>
###xml 773 776 773 774 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
Repeat addition processivity (Pi) was calculated using methods similar to those described previously [37], [38]. The normalized signals of the +6, +12, +18, +24, +30, and +36 elongation products were applied to the formula Pi  =  (Ti+6)/(Ti + Ti+6). First, repeat addition processivity was calculated for each pair of elongation products. Next, the repeat addition processivity values at each position were summed to determine the overall processivity. The overall processivity results of three independent experiments were averaged and the SEM was calculated. Average repeat addition processivity for mutant telomerases was then expressed relative to the wild type enzyme and the SEM was calculated. Statistical significance was assessed using GraphPad InStat version 3.00(R) (GraphPad Software).
###end p 48
###begin title 49
Primer binding assay
###end title 49
###begin p 50
###xml 60 63 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#174;</sup>
###xml 151 155 149 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Wyatt1">[28]</xref>
###xml 158 160 156 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 353 357 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Wyatt1">[28]</xref>
###xml 435 437 433 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 514 518 512 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Wyatt1">[28]</xref>
hTERT was synthesized in the absence of hTR with the RRL TNT(R) T7 Transcription-Translation System (Promega, Fisher Scientific Ltd.), as described in [28]. [35S]cysteine-labelled hTERT proteins were tested for the ability to interact with 5'-biotinylated oligonucleotides using a slightly modified version of the previously described DNA-binding assay [28], in which the primer mix was incubated on ice for 45-60 min prior to adding [35S]cysteine-labelled hTERT. Primer binding results were analyzed as described [28], with the exception that reaction products were quantified by phosphoimager analysis.
###end p 50
###begin title 51
Telomere restriction fragment analysis
###end title 51
###begin p 52
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hin</italic>
###xml 63 66 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rsa</italic>
###xml 250 251 246 247 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sub>
###xml 250 251 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sub>x</sub></italic>
###xml 285 287 277 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 801 804 787 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> 32</sup>
Telomeres were visualized by in-gel hybridization of HinfI and RsaI restriction enzyme-digested genomic DNA (5 microg) with a telomeric DNA probe (generously provided by Dr. J. Karlseder, Salk Institute for Biological Studies, La Jolla, CA), (TTAGGG)x, labelled with Klenow and [alpha-32P]dGTP (3000 Ci/mmol, 10 mCi/mL; GE Healthcare). Aliquots of digested DNA were electrophoresed through a 0.6% agarose gel at 500 Vh. Gels were denatured for 45 min in denaturation solution (0.5 M NaOH; 1.5 M NaCl), neutralized for 45 min in neutralization solution (1 M Tris, pH 8.0; 1.5 M NaCl), and dried at RT (45 min) and 60degreesC (45 min). The dried gel was subsequently denatured for 10 min and neutralized for 10 min before hybridization in 5x SSC (20x stock  = 3 M NaCl; 300 mM sodium citrate) containing 32P-labelled telomeric probe at 37degreesC for 20 h. Hybridized gels were washed three times in 2x SSC for 10 min (RT), washed once in nuclease-free water for 5 min (RT), dried for 20 min at 60degreesC, and exposed to a phosphoimager screen overnight. Mean telomere length was calculated from at least three independent experiments using OptiQuanttrade mark version 5.0 software (PerkinElmer, Inc.).
###end p 52
###begin title 53
beta-galactosidase staining
###end title 53
###begin p 54
###xml 217 218 217 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 262 263 256 257 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 451 452 439 440 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Adherent BJ cells grown in 10 cm culture dishes were washed in PBS (pH 7.2), fixed for 3-5 min at RT in PBS (pH 7.2) containing 0.5% gluteraldehyde (Sigma-Aldrich), washed with PBS (pH 7.2) supplemented with 1 mM MgCl2, and stained overnight at 37degreesC (no CO2) with fresh beta-galactosidase staining solution: PBS (pH 6.0) containing 1 mg/mL 5-bromo-4-chloro-3-indolyl beta-D-galactoside (X-Gal) (stock  = 20 mg/mL in dimethylformamide), 1 mM MgCl2, 120 microM potassium ferricyanide, and 120 microM potassium ferrocyanide. Staining was evident the next day; stained cells were washed in PBS (pH 7.2) and visualized with bright-field microscopy.
###end p 54
###begin title 55
Results
###end title 55
###begin title 56
###xml 58 66 58 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 41 46 <span type="species:ncbi:9606">human</span>
Q169 mediates the polymerase function of human telomerase in vitro
###end title 56
###begin p 57
###xml 130 138 130 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 355 364 355 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g002">Figure 2A</xref>
###xml 104 109 <span type="species:ncbi:9606">human</span>
###xml 210 215 <span type="species:ncbi:9606">human</span>
We first determined whether the evolutionarily-conserved Gln residue in the TEN domain was required for human telomerase activity in vitro using the telomere repeat amplification protocol (TRAP). We found that human telomerase reconstituted with hTERT Q169A, Q169D, or Q169N exhibited a dramatic reduction in catalytic activity compared to the WT enzyme (Figure 2A). Control reactions showed that RNase A inhibited these reactions, indicating that DNA synthesis was catalyzed by telomerase and not by contaminating polymerases present in RRL. The Q169D substitution was particularly disruptive and largely eliminated enzymatic activity, perhaps due to electrostatic repulsion between the polyanionic DNA backbone and electronegative carboxylic acid side-chain.
###end p 57
###begin title 58
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro telomerase activity of hTERT Q169 mutants.
###end title 58
###begin p 59
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A,</italic>
###xml 141 149 141 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 447 449 439 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B,</italic>
###xml 3 8 <span type="species:ncbi:9606">Human</span>
###xml 41 47 <span type="species:ncbi:9986">rabbit</span>
###xml 450 455 <span type="species:ncbi:9606">Human</span>
###xml 635 640 <span type="species:ncbi:9606">human</span>
A, Human telomerase was reconstituted in rabbit reticulocyte lysates (RRL) with hTR and FLAG-hTERT WT, Q169A, Q169D, or Q169N and tested for in vitro enzyme activity using the telomere repeat amplification protocol. RRL reconstitution reactions (1 microL) were assayed in the presence and absence of 5 microg RNAse A. The triangles represent a five-fold dilution of each reaction to confirm that the amplification assays were in the linear range. B, Human telomerase reconstituted in RRL with hTR and FLAG-hTERT WT, Q169A, Q169D, or Q169N was tested for activity using the conventional telomerase activity assay and an 18 nt canonical human telomeric primer, bio-TELO18. Mean telomerase activity within the first hexameric repeat was calculated from three independent experiments and reported relative to the WT enzyme. Mean values+/-SEM are shown at bottom of each lane. The asterisk indicates 22 nt elongation products, as determined by comparison with the mobility of a 5'-end-radiolabelled 18 nt telomeric primer containing 3'-biotin (not shown).
###end p 59
###begin p 60
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 279 283 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Kim1">[36]</xref>
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Kim2">[39]</xref>
###xml 652 661 652 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g002">Figure 2B</xref>
###xml 666 673 666 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007176-t001">Table 1</xref>
###xml 785 789 785 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Wyatt1">[28]</xref>
###xml 1051 1060 1051 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g002">Figure 2B</xref>
###xml 1415 1416 1415 1416 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</underline>
###xml 1411 1424 1411 1424 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-G<underline>G</underline>GTTAG-3&#8242;</named-content>
###xml 463 468 <span type="species:ncbi:9606">human</span>
###xml 726 731 <span type="species:ncbi:9606">human</span>
###xml 1714 1719 <span type="species:ncbi:9606">human</span>
###xml 1942 1947 <span type="species:ncbi:9606">human</span>
The TRAP is a highly sensitive method to detect telomerase activity. However, it does not distinguish between enzymes with catalytic defects (i.e. impaired DNA polymerization) and non-processive enzymes with translocation defects that synthesize less than four telomeric repeats [36], [39]. Therefore, we used the conventional telomerase activity assay (CTA) to gain more insight into the catalytic defects of the hTERT Q169 mutants. Similar to the TRAP results, human telomerase reconstituted with hTERT Q169A, Q169D, or Q169N exhibited markedly reduced activity compared to the WT enzyme when tested with an 18 nt telomeric ssDNA primer, bio-TELO18 (Figure 2B and Table 1). CTA assays were performed with bio-TELO18 because human telomerase exhibits robust activity with this primer [28], although we observed similar catalytic defects with a shorter primer, bio-TELO6 (data not shown). Quantification of three independent experiments showed that telomerase reconstituted with hTERT Q169A was approximately 20% as active as the WT enzyme (p<0.001) (Figure 2B). The activity defect was more severe for telomerases reconstituted with either hTERT Q169D or hTERT Q169N, which were only 11% and 14% as active as WT telomerase, respectively (p<0.001). We observed a striking defect in the ability of the Q169 mutants to incorporate the second nucleotide, which corresponds to the second G in the extension product 5'-GGGTTAG-3'. This could be explained if the Q169 mutants have reduced affinity for the nucleotide that would be incorporated at this position. However, we have been unable to address this question because kinetic studies and derivation of affinity constants cannot be performed with RRL-reconstituted human telomerase. This is due to the high abundance of endogenous RRL proteins and the inability to accurately quantify the concentration of functionally-competent telomerase. Similar arguments exist for FLAG-immunoprecipitated human telomerase. An alternative, but not necessarily independent explanation is that substitution of Q169 altered hTERT conformation, which prevented efficient nucleotide incorporation (below).
###end p 60
###begin p 61
###xml 111 119 111 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g003">Figure 3</xref>
###xml 758 762 758 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
Pulse-chase CTA experiments indicated that mutation of hTERT Q169 did not affect repeat addition processivity (Figure 3). A direct correlation was observed between the length of the extended pulse primer and the time that WT and Q169A telomerase was incubated with chase DNA, indicating that telomerase remained associated with bio-TELO18 and catalyzed processive DNA synthesis. Quantification of the repeat addition processivity within the first five telomeric repeats revealed that hTERT Q169A was at least 95% as processive as WT telomerase when pulsed with bio-TELO18 and chased with TELO18 (p>0.05). This data suggests that hTERT Q169 has a critical role in the first round of DNA synthesis but is less important for subsequent rounds of DNA synthesis (i.e. translocation). However, we cannot rule out a potential role for Q169 in repeat addition processivity since were unable to quantify the processivity of telomerase reconstituted with hTERT Q169D or Q169N.
###end p 61
###begin title 62
Repeat addition processivity of hTERT Q169 mutants.
###end title 62
###begin p 63
###xml 1192 1194 1182 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nd</italic>
Pulse-chase conventional telomerase activity assays were used to measure the repeat addition processivity of telomerase with bio-TELO18. The telomerase reaction was initiated with 1.5 microM bio-TELO18. Telomerase was allowed to extend bio-TELO18 for 5 min and then challenged with 200 microM chase primer (TELO18) for 5, 15, and 30 min. The first three lanes in each panel represent control reactions (left to right): pulse (5 min), reactions performed with pulse primers alone to show that telomerase can efficiently elongate this primer; pulse + chase, pulse and chase primers added simultaneously to demonstrate the efficiency of the chase conditions; chase (30 min), reactions performed with the chase primer alone to show that the non-biotinylated reaction products were not isolated on streptavidin beads. Repeat addition processivity within the first five repeats was calculated from three independent experiments. Mean values are reported+/-SEM at the bottom of each lane. Asterisks denote the position of the 22 nt elongation product, as determined by comparison with the mobility of a 5'-end-radiolabelled 18 nt telomeric oligonucleotide harboring a 3'-biotin residue (not shown). nd, not determined.
###end p 63
###begin title 64
Biochemical characterization of hTERT Q169
###end title 64
###begin p 65
###xml 217 219 217 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 273 282 273 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g004">Figure 4A</xref>
###xml 372 380 372 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 596 598 596 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 815 824 815 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g004">Figure 4B</xref>
###xml 866 868 866 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1177 1186 1177 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007176.s001">Figure S1</xref>
###xml 1264 1266 1264 1266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1377 1386 1377 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007176.s002">Figure S2</xref>
To investigate the basis for the activity defects, we determined whether Q169 modulates hTERT stability, conformation, and physical interactions with hTR. There was no appreciable difference in the protein levels of [35S]cysteine-labelled hTERT WT, Q169A, Q169D, or Q169N (Figure 4A), indicating that Q169 mutagenesis does not have a significant impact on hTERT stability in vitro. However, it remained possible that Q169 mutation might induce a conformational change in hTERT that inhibited enzyme activity without compromising protein stability. Therefore, RRL containing comparable levels of [35S]cysteine-labelled WT or Q169 mutated hTERT was subjected to limited proteolysis using chymotrypsin. The hTERT Q169A, Q169D, and Q169N mutants were found to be more sensitive to chymotrypsin digestion than WT hTERT (Figure 4B). Specifically, the signal intensity of [35S]cysteine-labelled proteolytic fragments migrating at approximately 20 kDa was diminished in hTERT Q169A, Q169D, and Q169N. This was an hTR-independent effect because the proteolytic fragments derived from hTERT reconstituted in the presence of hTR were indistinguishable from those observed in its absence (Figure S1). This observation was confirmed with time-course proteolytic digestions of [35S]cysteine-labelled hTERT WT, Q169A, Q169D, or Q169N that were synthesized in the presence and absence of hTR (Figure S2).
###end p 65
###begin title 66
Biochemical analysis of hTERT Q169 mutants.
###end title 66
###begin p 67
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A,</italic>
###xml 370 372 366 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B,</italic>
###xml 436 438 432 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 703 705 693 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C,</italic>
###xml 782 784 768 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 858 860 844 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
A, Mutation of hTERT Q169 does not compromise protein stability. SDS-PAGE and autoradiography was used to assess protein expression and stability in RRL (left to right): pCI vector alone, FLAG-hTERT WT, FLAG-hTERT Q169A, FLAG hTERT Q169D, and FLAG-hTERT Q169N. RRL reactions (2 microL) were resolved by 8% SDS-PAGE and visualized by autoradiography and phosphorimaging. B, hTERT Q169 mediates hTERT conformation. Comparable amounts of [35S]cysteine-labelled FLAG-hTERT WT, Q169A, Q169D, or Q169N was incubated with 0, 10, 100, or 1000 ng/mL chymotrypsin at 30degreesC for 2 min and resolved by 12% SDS-PAGE. Arrows indicate the proteolytic fragments that are diminished upon substitution of hTERT Q169. C, Substitution of hTERT Q169 does not abrogate hTERT-hTR interactions. [alpha-32P]UTP-labelled hTR (indicated by asterisks) was coimmunoprecipiated with [35S]cysteine-labelled FLAG-hTERT WT, Q169A, Q169D, and Q169N (indicated by arrow). Coimmunoprecipitates were resolved by 4-15% SDS-PAGE and visualized by autoradiography and phosphorimaging.
###end p 67
###begin p 68
###xml 232 234 232 234 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 430 439 430 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007176.s003">Figure S3</xref>
To gain insight into the identity of the proteolytic fragments at approximately 20 kDa, we performed limited proteolysis on truncated hTERT proteins containing the first 300 amino acids. A comparison of the proteolytic profiles of [35S]cysteine-labelled 1-300 hTERT WT and Q169A, Q169D, and Q169N revealed a reduction in the 20 kDa proteolytic fragment in the Q169 mutants, similar to the results obtained with full length hTERT (Figure S3). This provides the first experimental evidence that Q169 is important for the structure of the hTERT N-terminus.
###end p 68
###begin p 69
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Beattie2">[34]</xref>
###xml 166 170 166 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Moriarty1">[35]</xref>
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Beattie3">[40]</xref>
###xml 372 374 368 370 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 398 400 394 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 460 462 456 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 556 558 548 550 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 590 599 582 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g004">Figure 4C</xref>
###xml 325 330 <span type="species:ncbi:9606">human</span>
Interactions between hTERT and hTR are essential for telomerase activity and some mutations in hTERT that impair hTR-binding reconstitute nonfunctional enzymes [34], [35], [40]. Thus, defects in hTERT-hTR assembly could potentially explain the loss of activity observed with the hTERT Q169 mutants. To test this possibility, human telomerase was reconstituted with [alpha-32P]UTP-labelled hTR and [35S]cysteine-labelled-FLAG-hTERT WT, Q169A, Q169D, or Q169N. [35S]cysteine-labelled hTERT was immunoprecipitated with FLAG antibodies and analyzed for [alpha-32P]UTP-labelled hTR. As shown in Figure 4C, the hTERT Q169 mutants bound hTR as efficiently as hTERT WT, indicating that the functional defects observed with these mutants were not due to abrogated hTERT-hTR interactions.
###end p 69
###begin title 70
hTERT Q169 mutants retain sequence-specific ssDNA-binding activity
###end title 70
###begin p 71
###xml 299 303 299 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Autexier1">[11]</xref>
###xml 596 603 596 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007176-t001">Table 1</xref>
###xml 605 609 605 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Wyatt1">[28]</xref>
###xml 690 698 690 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 700 716 700 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g005">Figures 5A and B</xref>
###xml 871 880 871 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g005">Figure 5A</xref>
###xml 850 855 <span type="species:ncbi:9606">human</span>
Telomeric primers have to be positioned correctly within the telomerase active site to initiate reverse transcription. In addition to primer-template interactions, this requires interactions between the TERT RT domain and DNA 3'-end, as well as between the N-terminus (anchor region) and DNA 5'-end [11]. Thus, suboptimal interactions between hTERT and DNA primers could explain the activity defects observed with hTERT Q169 mutants. We used a recently-developed DNA-binding assay to characterize physical interactions between hTERT WT, Q169A, Q169D, and Q169N and 5'-biotinylated ssDNA primers (Table 1) [28]. We found that the Q169 mutants retained sequence-specific DNA-binding activity in vitro (Figures 5A and B). When compared with hTERT WT, however, the Q169 mutants exhibited subtle differences in their interactions with specific lengths of human telomeric DNA (Figure 5A). The relative strength of the interaction between short telomeric primers (bio-TELO12 and bio-TELO6) and each of the Q169 mutants was greater than that observed for hTERT WT. This was also observed between hTERT Q169A and bio-TELO24, and may reflect tighter binding of the primers to the Q169 mutants. In contrast, the relative strength of the interaction between hTERT Q169D or Q169N and bio-TELO30, the longest primer we tested, was significantly reduced.
###end p 71
###begin title 72
hTERT Q169 mutants interact sequence-specifically with telomeric ssDNA.
###end title 72
###begin p 73
###xml 143 145 143 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A,</italic>
###xml 191 193 191 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B,</italic>
###xml 260 267 260 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007176-t001">Table 1</xref>
###xml 167 172 <span type="species:ncbi:9606">human</span>
###xml 198 203 <span type="species:ncbi:9606">human</span>
The primer binding assay was used to investigate interactions between hTERT WT and Q169 mutants and 5'-biotinylated ssDNA primers comprised of A, different lengths of human telomeric DNA and B, non-human telomeric or random DNA. Primer sequences are listed in Table 1. hTERT-DNA complexes were immobilized on neutravidin beads and separated by 8% SDS-PAGE and visualized with autoradiography and phosphorimaging (left panels). Quantification and statistical analysis of at least three independent experiments is shown in the graphs (right panels). Mean values are reported+/-SEM. Asterisks denote levels of statistical significance compared to the interaction between hTERT WT and the corresponding primer; p<0.05 (*) and p<0.01 (**).
###end p 73
###begin p 74
###xml 176 185 176 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g005">Figure 5B</xref>
###xml 682 693 682 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tetrahymena</italic>
###xml 786 799 786 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 827 836 827 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g005">Figure 5B</xref>
###xml 983 989 983 989 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TTGGGG</named-content>
###xml 991 995 991 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Morin1">[22]</xref>
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 786 799 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 819 824 <span type="species:ncbi:4932">Yeast</span>
###xml 913 918 <span type="species:ncbi:9606">human</span>
We next tested the Q169 mutants for interactions with non-human telomeric or random ssDNA to determine whether Q169 was important for hTERT's sequence-specificity. As shown in Figure 5B, hTERT Q169A, Q169D, and Q169N demonstrated sequence-specific DNA-binding that was indistinguishable from hTERT WT. The interactions between Q169 mutants and primers containing either 18 nt (bio-antiTELO18) or 24 nt (bio-pBR and bio-BBP) of non-telomeric DNA were not statistically different from those observed with hTERT WT (p>0.05). When tested with primers representing the telomeres of other organisms, hTERT WT and Q169 mutants interacted very efficiently with a primer containing 18 nt of Tetrahymena telomeric DNA (bio-Tetrahymena) and much less efficiently with a primer containing 15 nt of S. cerevisiae telomeric DNA (bio-Yeast) (Figure 5B). The interaction with bio-Tetrahymena is consistent with the ability of WT human telomerase to elongate primers containing this G-rich sequence (TTGGGG) [22].
###end p 74
###begin title 75
Q169 mediates the ability of truncated hTERT proteins to interact with ssDNA
###end title 75
###begin p 76
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Finger1">[29]</xref>
###xml 506 510 506 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Wyatt1">[28]</xref>
###xml 598 607 598 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g006">Figure 6A</xref>
###xml 976 985 976 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g005">Figure 5A</xref>
###xml 1164 1173 1164 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g006">Figure 6B</xref>
###xml 1214 1230 1214 1230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g006">Figures 6A and B</xref>
###xml 1100 1105 <span type="species:ncbi:4932">yeast</span>
###xml 1120 1125 <span type="species:ncbi:4932">Yeast</span>
###xml 1369 1374 <span type="species:ncbi:9606">human</span>
TERT contains multiple DNA-binding regions that make it difficult to assess how one amino acid influences DNA-binding [29]. We therefore introduced the Q169 mutations into the isolated hTERT TEN domain (amino acids 1-196) and the tested these mutants for DNA-binding. However, we were unable to detect stable interactions between the TEN domain and telomeric ssDNA primers (data not shown). Therefore, the Q169A, Q169D, and Q169N mutations were cloned into an hTERT fragment comprised of residues 1 to 300 [28]. Each of the hTERT 1-300 constructs exhibited readily apparent ssDNA-binding activity (Figure 6A). However, the Q169 substitutions caused a reduction in the relative strength of the interactions between hTERT 1-300 and short telomeric primers (bio-TELO12 and bio-TELO6). This result provided an interesting contrast to that observed with full length proteins, where mutation of Q169 increased the apparent strength of the interaction with bio-TELO12 and bio-TELO6 (Figure 5A). Furthermore, the 1-300 hTERT Q169 mutants showed a marked decrease in the interaction with primers comprised of yeast telomere (bio-Yeast) or random (bio-pBR and bio-BBP) DNA (Figure 6B). Taken together, the data presented in Figures 6A and B indicate that Q169 is involved in the ssDNA-binding activity of the hTERT N-terminus and thus, contributes to anchor site interactions in human telomerase.
###end p 76
###begin title 77
Q169 mediates physical interactions between truncated hTERT proteins and ssDNA.
###end title 77
###begin p 78
###xml 186 188 186 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A,</italic>
###xml 234 236 234 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B,</italic>
###xml 272 279 272 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007176-t001">Table 1</xref>
###xml 210 215 <span type="species:ncbi:9606">human</span>
###xml 241 246 <span type="species:ncbi:9606">human</span>
The primer binding assay was used to test the ability of truncated hTERT proteins comprised of amino acids 1-300 (WT and Q169 mutants) to bind 5'-biotinylated ssDNA primers comprised of A, different lengths of human telomeric DNA and B, non-human telomeric or random DNA (Table 1). hTERT-DNA complexes were immobilized on neutravidin beads and separated by 8% SDS-PAGE and visualized with autoradiography and phosphorimaging (left panels). Quantification and statistical analysis of at least three independent experiments is in graphical format (right panels) and the mean is reported+/-SEM. Asterisks denote levels of statistical significance compared to hTERT 1-300 WT binding to the corresponding DNA primer; p<0.05 (*), p<0.01 (**), and p<0.001 (***).
###end p 78
###begin title 79
###xml 40 45 <span type="species:ncbi:9606">human</span>
Q169 mediates the cellular functions of human telomerase
###end title 79
###begin p 80
###xml 14 22 14 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 440 448 440 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 104 109 <span type="species:ncbi:9606">human</span>
###xml 174 178 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 288 293 <span type="species:ncbi:9606">human</span>
To extend our in vitro studies, we determined if Q169 mediates the biological activity of telomerase in human cells. hTERT Q169A was stably expressed in telomerase positive (SV40 large T-antigen transformed embryonic kidney cells; 293T) and telomerase negative (foreskin fibroblasts; BJ) human cells. Q169A was chosen as a representative mutant for these experiments since this substitution was the least detrimental to telomerase activity in vitro.
###end p 80
###begin p 81
###xml 74 83 74 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g007">Figure 7A</xref>
###xml 293 302 293 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g007">Figure 7A</xref>
###xml 492 501 492 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g007">Figure 7B</xref>
###xml 798 807 798 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g007">Figure 7B</xref>
###xml 1166 1170 1166 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Hahn1">[41]</xref>
###xml 1172 1176 1172 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Zhang1">[42]</xref>
We first investigated the cellular function of hTERT Q169A in 293T cells. Figure 7A shows that anti-FLAG-immunoprecipitated hTERT WT exhibited robust TRAP activity whereas the Q169A mutant was consistently inactive. The loss of telomerase activity was not due to abrogated protein expression (Figure 7A) or nuclear exclusion (data not shown). As expected, telomere elongation was observed in 293T cells expressing hTERT WT but not in those expressing the catalytically inactive Q169A mutant (Figure 7B). As mentioned above, 293T cells contain functional endogenous telomerase. This allowed us to investigate whether hTERT Q169A inhibited the action of endogenous telomerase at telomeres. Bulk telomere length in cells stably expressing hTERT Q169A was similar to that of vector-only control cells (Figure 7B), although the vector-only cells have slightly longer telomeres upon infection. In both of these cell lines, telomeres do not shorten with increased passage number. Furthermore, neither the vector only cells nor the cells expressing Q169A underwent apoptosis and can be maintained in culture (data not shown), unlike other dominant negative alleles of hTERT [41], [42]. Collectively, these data indicate that hTERT Q169A does not function as a dominant negative protein in 293T cells.
###end p 81
###begin title 82
###xml 94 99 <span type="species:ncbi:9606">human</span>
hTERT Q169 is required for telomerase activity and telomere length-maintenance in transformed human cells.
###end title 82
###begin p 83
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A,</italic>
###xml 49 53 49 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">puro</sub>
###xml 60 64 60 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">puro</sub>
###xml 88 92 88 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">puro</sub>
###xml 553 555 545 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">na</italic>
###xml 573 575 565 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B,</italic>
A, Extracts of 293T cells stably expressing pBABEpuro, pBABEpuro-FLAG-hTERT WT, or pBABEpuro-FLAG-hTERT Q169A were immunoprecipitated with anti-FLAG antibodies. FLAG-hTERT was eluted from the beads by competition with excess 3 x FLAG peptide. 2 microL of eluate was tested for telomerase activity by the telomere repeat amplification protocol (top panel) and 35 microL was resolved by 8% SDS-PAGE and examined for hTERT expression by Western blotting with anti-hTERT antibodies (bottom panel). The mean population doubling is indicated above each lane. na, not applicable. B, Bulk telomere length was measured using the terminal restriction fragment analysis. Mean telomere length and standard error of the mean (SEM) was calculated from at least three independent experiments and is indicated below each lane. The mean population doubling is indicated above each lane. Arrows are included for visual clarification and represent the approximate mean of each sample.
###end p 83
###begin p 84
###xml 341 350 341 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g008">Figure 8A</xref>
###xml 475 484 475 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g008">Figure 8A</xref>
###xml 635 644 635 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g008">Figure 8B</xref>
###xml 842 858 839 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g008">Figures 8C and D</xref>
###xml 874 878 871 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Dimri1">[43]</xref>
###xml 1063 1075 1060 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g008">Figures 8B&#8211;D</xref>
###xml 1462 1467 <span type="species:ncbi:9606">human</span>
The cellular function of hTERT Q169A was also investigated in normal diploid fibroblasts (BJ cells). Telomerase negative BJ cells provide a strong cellular contrast to the telomerase positive 293T cells and thus, control for cell line-dependent phenotypes. Expression of hTERT WT, but not Q169A, conferred BJ cells with telomerase activity (Figure 8A). The lack of telomerase activity in immunoprecipitates containing hTERT Q169A was not due to abrogated protein expression (Figure 8A). Furthermore, stable expression of hTERT WT induced telomere elongation during early passages and telomere length maintenance during later passages (Figure 8B). These cultures completed approximately three times more mean population doublings (mpd) than the vector-only control cells, and did not exhibit senescence-associated beta-galactosidase activity (Figures 8C and D, respectively) [43]. The BJ cells expressing hTERT Q169A exhibited defects in telomere length maintenance, exhausted their replicative potential after 25 mpd, and did not surmount replicative senescence (Figures 8B-D). Although the BJ cells expressing hTERT Q169 appear shorter at mpd 22 than the vector only control cells, the bulk telomere length of the control cells were slightly longer upon infection than in the hTERT Q169A cells due to the fact that these are polyclonal cell population However, the rates of telomere shortening in these cells are similar. Thus, mutation of hTERT Q169 inhibited human telomerase function in living cells.
###end p 84
###begin title 85
###xml 123 128 <span type="species:ncbi:9606">human</span>
hTERT Q169 is required for telomerase activity, telomere length-maintenance, and hTERT-mediated immortalization in primary human cell lines.
###end title 85
###begin p 86
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A,</italic>
###xml 49 53 49 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">puro</sub>
###xml 60 64 60 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">puro</sub>
###xml 88 92 88 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">puro</sub>
###xml 553 555 545 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B,</italic>
###xml 961 963 953 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C,</italic>
###xml 1187 1189 1179 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D,</italic>
A, Extracts from BJ cells stably expressing pBABEpuro, pBABEpuro-FLAG-hTERT WT, or pBABEpuro-FLAG-hTERT Q169A were immunoprecipitated with anti-FLAG antibodies. FLAG-hTERT was eluted from the beads by competition with excess 3 x FLAG peptide. 2 microL of eluate was tested for telomerase activity by the telomere repeat amplification protocol (top panel) and 35 microL was resolved by 8% SDS-PAGE and examined for hTERT expression by Western blotting with anti-hTERT antibodies (bottom panel). The mean population doubling is indicated above each lane. B, Bulk telomere length was measured using the terminal restriction fragment analysis. Mean telomere length and standard error of the mean (SEM) was calculated from at least three independent experiments and is indicated below each lane. The mean population doubling of each culture is indicated above the lane. Arrows are included for visual clarification and represent the approximate mean of each sample. C, Biological activity of hTERT Q169A was investigated by continuously passaging BJ cells to determine if the cultures entered replicative senescence or bypassed this proliferative blockade, as determined using growth curves. D, beta-galactosidase activity at pH 6.0, a well-known marker of replicative senescence, was monitored using conventional staining techniques to detect blue-colored cells. Representative BJ cells stably expressing the empty vector or FLAG-hTERT Q169A exhibited blue staining that coincided with the cessation of proliferation. In contrast, cells stably expressing FLAG-hTERT stained negative for beta-galactosidase activity (pH 6.0). The mean population doubling of each culture is indicated in parenthesis.
###end p 86
###begin title 87
Discussion
###end title 87
###begin title 88
###xml 28 33 <span type="species:ncbi:9606">human</span>
hTERT Q169 is essential for human telomerase activity
###end title 88
###begin p 89
###xml 443 447 443 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Autexier1">[11]</xref>
Important questions in telomerase biochemistry pertain to the mechanisms by which the enzyme recognizes and orientates telomeric ssDNA in the active site and catalyzes processive telomere synthesis. A long-standing notion is that telomerase has two modes of primer recognition: initial recognition of a telomere sequence and/or structure at the DNA 5'-end and subsequent identification of the 3'-terminus to prime the addition of telomeric nt [11]. Template-independent enzyme-DNA interactions are known as anchor site interactions and a subset of these are believed to confer telomerase with the property of repeat addition processivity. After synthesizing a complete telomeric repeat, Watson-Crick base pairs between the DNA 3'-end and RNA template are melted so that the nascent DNA 3'-end can be repositioned with the template for the next round of telomere synthesis. During this dynamic process, the telomerase anchor site(s) remains associated with upstream nt and prevents the enzyme from dissociating off the DNA primer.
###end p 89
###begin p 90
###xml 29 40 29 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tetrahymena</italic>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Romi1">[30]</xref>
###xml 209 213 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Jacobs1">[33]</xref>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Romi1">[30]</xref>
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Jacobs1">[33]</xref>
###xml 518 525 518 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 525 529 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Lue1">[31]</xref>
###xml 680 688 680 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 693 700 693 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1042 1049 1042 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1343 1347 1343 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Lue1">[31]</xref>
###xml 1349 1353 1349 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Friedman1">[44]</xref>
###xml 492 497 <span type="species:ncbi:4932">yeast</span>
###xml 569 574 <span type="species:ncbi:9606">human</span>
###xml 1190 1195 <span type="species:ncbi:4932">yeast</span>
The crystal structure of the Tetrahymena TEN domain revealed a ssDNA-binding groove on the surface that contained several phylogenetically-conserved residues, including the Gln residue investigated here [30], [33]. Alanine mutagenesis of tTERT Q168 significantly impaired telomerase activity without affecting repeat addition processivity and identified a role for this residue in ciliate telomerase anchor site interactions [30], [33]. The corresponding mutation in Est2p severely decreased yeast telomerase activity in vivo[31]. Here, we show for the first time that human telomerase reconstituted with hTERT Q169A, Q169D, or Q169N exhibits severe defects in DNA polymerization in vitro and in vivo, indicating that the invariant Gln residue has an evolutionarily-conserved role in telomerase function. Our study provides novel insight into the role of this residue by revealing its importance for the ability of telomerase to incorporate nucleotides at the second position of the RNA template. Importantly, the loss of telomerase activity in vivo was not due to nuclear exclusion or abrogated protein expression, although protein levels were reduced compared to hTERT WT. Interestingly, yeast strains expressing endogenous Est2p Q146A suffered severe growth defects and telomere attrition, and exhibited a reduction in Est2p protein levels [31], [44]. Thus, it appears that living cells do not tolerate high expression levels of TERT proteins harboring mutations of the invariant Gln residue.
###end p 90
###begin p 91
###xml 571 576 <span type="species:ncbi:9606">human</span>
In the absence of crystallographic data of hTERT, we can only speculate on the mechanism underlying the severity of the Q169D and Q169N mutations in relation to Q169A. As mentioned previously, the non-conservative Q169D substitution could cause electrostatic repulsion between the polyanionic DNA backbone and electronegative carboxylic acid side-chain. Our observation that the conservative Q169N does not rescue the catalytic phenotype indicates that both the length and the hydrogen-bonding potential of the side chain at position 169 are critical for the activity of human telomerase. The finding that hTERT Q169A reconstitutes weak telomerase activity is likely due to the fact that this is a neutral amino acid substitution. Although both Ala and Asn potentially eliminate important hydrogen-bonding interactions that would be normally fulfilled by Gln, the Q169N substitution is more detrimental to activity. One interpretation of this data is that the Asn substitution also introduces an unfavorable interaction whereby the shorter side chain prevents the amide group from satisfying its hydrogen-bonding potential.
###end p 91
###begin p 92
###xml 203 211 203 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Lue1">[31]</xref>
###xml 544 550 544 550 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TTGGGG</named-content>
###xml 555 561 555 561 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TTAGGG</named-content>
###xml 623 627 623 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 629 632 629 632 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#8211;3</sub>
###xml 636 639 636 639 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;6</sub>
###xml 643 656 643 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. cerevisiae</italic>
###xml 658 662 658 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Wang1">[45]</xref>
###xml 407 412 <span type="species:ncbi:9606">human</span>
###xml 591 596 <span type="species:ncbi:4932">yeast</span>
###xml 643 656 <span type="species:ncbi:4932">S. cerevisiae</span>
Finally, we note that this residue appears to have evolved some species-specific functions. Alanine substitution of the corresponding residue in Est2p significantly impaired repeat addition processivity in vitro[31]. One intriguing explanation for these differences might be that telomerase uses different mechanisms to interact with different sequences of telomeric DNA. It is conceivable that ciliate and human telomerase use similar mechanisms to bind and synthesize telomeric DNA because of the high degree of telomere sequence similarity (TTGGGG and TTAGGG, respectively). In contrast, yeast telomeres are degenerate (e.g. G2-3(TG)1-6 in S. cerevisiae) [45] and different molecular mechanisms might be used for telomere length maintenance in this organism.
###end p 92
###begin title 93
Q169 alters the sensitivity of the hTERT N-terminus to proteolytic digestion
###end title 93
###begin p 94
###xml 84 88 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Autexier1">[11]</xref>
###xml 257 261 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Autexier1">[11]</xref>
###xml 295 306 295 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tetrahymena</italic>
###xml 438 442 438 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Romi1">[30]</xref>
###xml 444 448 444 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Jacobs1">[33]</xref>
###xml 846 850 846 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Romi1">[30]</xref>
###xml 852 856 852 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Jacobs1">[33]</xref>
Telomerase is thought to contain template-distal and template-proximal anchor sites [11]. It has been speculated that a conformational change in the template-proximal anchor site is required for telomerase to transition into an elongation-competent complex [11]. Structure-function studies with Tetrahymena telomerase suggested that the ssDNA-binding groove on the surface of the TEN domain formed part of a template-proximal anchor site [30], [33]. Photo-cross-linking studies with tTERT and short telomeric ssDNA suggested that the TEN domain was displaced relative to the catalytic site during telomere synthesis. It was proposed that this movement was needed to reposition the template-proximal anchor site relative to the active site and correctly orientate the DNA primer or DNA-RNA heteroduplex in the active site during primer elongation [30], [33].
###end p 94
###begin p 95
###xml 788 796 788 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
In this work, we investigated the structural significance of hTERT Q169 directly by using limited proteolysis to monitor the conformational flexibility of mutant proteins. Importantly, our results indicated that the overall conformation of hTERT Q169A, Q169D, and Q169N was intact. However, the NTE of the Q169 mutants was more sensitive to chymotrypsin proteolysis than hTERT WT. This is interpreted as evidence that Q169 is important for the conformation of the hTERT N-terminus. We believe that that a small fraction of the mutant proteins attained WT conformation because there was not a complete loss of the 20 kDa fragments. It is possible that these Q169 mutants are catalytically competent and thus, are responsible for the low levels of processive telomerase activity we observe in vitro (discussed below).
###end p 95
###begin title 96
hTERT Q169 mutants physically interact with hTR
###end title 96
###begin p 97
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Moriarty2">[46]</xref>
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Rouda1">[47]</xref>
TERT contains an essential and universally-conserved telomerase RNA-binding domain (TRBD) that makes extensive contacts with TR and represents the major TR-binding domain [46], [47]. It seemed unlikely that substitution of hTERT Q169 would disrupt hTERT-hTR interactions since this residue is not located in the TRBD. We confirmed here that hTERT Q169 is not involved in critical hTERT-hTR interactions. However, we cannot rule out the possibility that Q169 substitution causes small changes in hTR-binding that are masked in the context of the full length protein. Similarly, Q169 could regulate conformational changes in hTR or the RNP complex that are required for telomerase activity.
###end p 97
###begin title 98
Q169 mediates ssDNA-binding activity in hTERT
###end title 98
###begin p 99
###xml 144 152 144 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 718 722 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Wyatt1">[28]</xref>
###xml 724 728 724 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Finger1">[29]</xref>
In this work we show that hTERT proteins containing Q169A, Q169D, or Q169N mutations retained telomere sequence-specific ssDNA-binding activity in vitro. However, when compared to hTERT WT, the Q169 mutants exhibited subtle differences in the relative strength of the interactions with telomeric ssDNA. In parallel, we investigated the DNA-binding properties of hTERT 1-300 variants containing the Q169 substitutions. hTERT 1-300 Q169A, Q169D, and Q169N also retained telomeric ssDNA-binding activity and demonstrated subtle differences in the relative strength of protein-DNA interactions when compared to 1-300 WT. While the presence of multiple DNA-binding sites in TERT complicates the interpretation of this data [28], [29], these studies clearly indicate that Q169 is involved in protein-telomeric DNA interactions, thereby identifying a novel residue in hTERT that regulates ssDNA-binding activity (discussed below). Future studies are required to determine Q169 has a direct or indirect effect on DNA-binding.
###end p 99
###begin p 100
###xml 387 391 387 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Wyatt1">[28]</xref>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Finger1">[29]</xref>
###xml 544 552 544 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 679 683 679 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Wyatt1">[28]</xref>
###xml 685 689 685 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Finger1">[29]</xref>
###xml 713 722 713 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g005">Figures 5</xref>
###xml 727 728 727 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g006">6</xref>
###xml 1797 1805 1797 1805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1933 1941 1933 1941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1941 1945 1941 1945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Wyatt1">[28]</xref>
###xml 2324 2333 2324 2333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007176-g006">Figure 6B</xref>
###xml 2506 2514 2506 2514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2656 2660 2656 2660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Romi1">[30]</xref>
###xml 2662 2666 2662 2666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Jacobs1">[33]</xref>
###xml 2812 2816 2812 2816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 2301 2306 <span type="species:ncbi:4932">yeast</span>
Interestingly, the hTERT Q169 mutations cause an increase in the relative strength of the interaction between the full length protein and short telomeric ssDNA primers whereas they decrease the interactions between hTERT 1-300 and these primers. We have previously identified multiple DNA-binding regions throughout the hTERT protein, including the N-terminus, RT domain, and C-terminus [28]. Similar results have now been reported for ciliate TERT [29]. Importantly, the DNA-binding regions appear to co-operate during telomeric ssDNA-binding in vitro and establish a dynamic 'DNA-binding equilibrium' in which the primer can interact with any or all of the DNA-binding domains [28], [29]. The data presented in Figures 5 and 6 suggests that the Q169 mutations have disrupted an important DNA-binding domain in the hTERT N-terminus thereby favoring an interaction with the remaining DNA-binding domains. Our observation that short ssDNA primers interact with the full length Q169 mutants to a greater extent than wild type hTERT implies that in the context of full length hTERT, Q169 negatively regulates the overall strength of the interaction with short telomeric primers. The apparent decrease in the strength of the interaction between bio-TELO30 and hTERT Q169D and Q169N, however, implies that Q169 may also be required to stabilize interactions with longer stretches of telomeric ssDNA. In contrast to full length hTERT, mutation of Q169 decreases the interaction between short telomeric primers and hTERT 1-300. One logical explanation for this decrease is that the 1-300 mutant lacks many of the previously identified DNA-binding regions in hTERT. Thus, Q169 has an important role in stabilizing the interactions that occur between the hTERT N-terminus and short telomeric ssDNA primers in vitro. Importantly, we have previously shown that the hTERT 1-300 fragment has a strong non-sequence-specific ssDNA-binding activity in vitro[28]. We interpreted this to mean that the hTERT N-terminus contains a strong ssDNA-binding activity but regions beyond the N-terminus are important for TTAGGG-specific ssDNA-binding. We show here that substitution of Q169 in the context of hTERT 1-300 causes a significant decrease in the ability of this fragment to bind ssDNA primers comprised of random or yeast telomeric ssDNA (Figure 6B). This observation identifies a previously unrecognized role for hTERT Q169 in regulating sequence-specific interactions between the protein's N-terminus and ssDNA primers in vitro. Our data supports previous studies that identified a potential role for Q168 in mediating ciliate telomerase's affinity for telomeric ssDNA [30], [33]. Collectively, these studies indicate that the Gln residue has an evolutionarily-conserved role in regulating TERT-telomeric ssDNA interactions (i.e. anchor site interactions).
###end p 100
###begin title 101
Conceptual model to describe the catalytic phenotype of hTERT Q169 mutants
###end title 101
###begin p 102
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 143 147 143 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Zaug1">[32]</xref>
###xml 432 436 432 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Zaug1">[32]</xref>
###xml 1202 1206 1202 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Cramer1">[48]</xref>
###xml 1208 1212 1208 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Cramer2">[49]</xref>
Recently, Zaug et al. proposed a model for telomerase activity in which the catalytic cycle is regulated by a series of conformational changes [32]. It was suggested that telomerase initiates DNA synthesis when the TEN domain is in close proximity to the remainder of the RNP ('closed state'). This conformation is regulated by an intramolecular protein-protein interaction between the TEN domain and an as yet unidentified residue [32]. Once the first round of telomere synthesis is complete, this interaction is broken and the TEN domain is displaced relative to the catalytic site, which relaxes the RNP into an 'open state'. Displacement of the TEN domain repositions the template-proximal anchor site and template region, and restores base-pairing between the DNA 3'-end and template 5'-end. It is thought that the DNA 5'-end slides through the ssDNA-binding groove on the TEN domain, which signals the RNP to return to the closed state for the next round of telomere synthesis. This model invokes conformation changes within telomerase that are similar to those described for bacterial and eukaryotic RNA polymerases during the transition from transcription initiation to elongation (reviewed in [48], [49]). For example, the initial loading of promoter DNA onto RNA polymerase II triggers a series of structural changes that include the closure of an evolutionarily-conserved 'clamp' over the template and transcript. Clamp closure converts the enzyme from an open to a closed state that is required for transcription elongation. It is intriguing to speculate that the TEN domain could be involved in processes that are similar to the RNA polymerase clamp structure.
###end p 102
###begin p 103
###xml 201 205 201 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 627 635 627 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 977 982 977 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1047 1051 1047 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007176-Zaug1">[32]</xref>
###xml 475 480 <span type="species:ncbi:9606">human</span>
We interpret the increased protease-sensitivity of full length and 1-300 hTERT Q169 mutants as evidence that the N-terminus adopts a conformation that is more accessible to chymotrypsin than WT hTERT (i.e. greater conformational flexibility). We speculate that the mutants cannot easily convert between open and closed states (above), which alters critical telomerase-DNA interactions and causes severe catalytic defects. This seems particularly important for the ability of human telomerase to incorporate nucleotides at the second position of the hTR template. We suggest that the minimal activity observed with Q169 mutants in vitro stems from a small population of enzymes that correctly orientate the DNA primer and/or DNA-RNA hybrid in the active site to catalyze telomere synthesis. This is consistent with the fact that we do not observe a complete loss of the 20 kDa proteolytic fragment in our limited proteolysis experiments. According to the model proposed by Zaug et al., Q169 is not directly involved in repeat addition processivity [32], which is consistent with our observation that hTERT Q169A demonstrates normal repeat addition processivity. We propose that the mechanism by which Q169 regulates telomerase activity involves conformational changes that promote optimal enzyme-primer-substrate interactions and facilitate the efficient incorporation of nucleotides during the first round of telomere synthesis.
###end p 103
###begin title 104
Perspectives
###end title 104
###begin p 105
###xml 709 716 709 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 68 73 <span type="species:ncbi:9606">human</span>
###xml 293 298 <span type="species:ncbi:9606">human</span>
###xml 817 822 <span type="species:ncbi:9606">human</span>
In summary, we show that Q169 is a functionally critical residue in human telomerase and provide the first detailed evidence regarding the biochemical and cellular significance of this evolutionarily-conserved Gln residue in higher eukaryotes. The intimate relationship between telomerase and human disease underscores the importance for structure-function studies that elucidate regions in hTERT that could be amenable to therapeutic intervention. Our studies are necessary, but not sufficient, for a complete understanding of how the TEN domain contributes to telomerase structure, activity, and telomere length maintenance in higher eukaryotes. Importantly, since Q169 is essential for telomerase activity in vivo, this residue could represent a novel target for therapeutic intervention of telomerase activity in human diseases like cancer.
###end p 105
###begin title 106
Supporting Information
###end title 106
###begin p 107
Q169 mediates hTERT conformation independently of hTR. RRL containing in vitro transcribed hTR and [35S]cysteine-labelled FLAG-hTERT WT, Q169A, Q169D, or Q169N was incubated with 0, 10, 100, or 1000 ng/mL chymotrypsin at 30degreesC for 2 min. 15 microL proteolysis reactions contained comparable amounts of [35S]cysteine-labelled hTERT. Reactions were terminated by the addition of SDS-PAGE loading buffer and boiling (5 min). Following digestion, products were resolved by 12% SDS-PAGE and visualized by autoradiography and phosphorimaging. Arrows indicate the proteolytic fragments that are diminished upon substitution of hTERT Q169.
###end p 107
###begin p 108
(0.85 MB TIF)
###end p 108
###begin p 109
Click here for additional data file.
###end p 109
###begin p 110
Time-course proteolytic digestion of hTERT WT and Q169 mutants. RRL containing A, [35S]cysteine-labelled FLAG-hTERT WT, Q169A, Q169D, or Q169N or B, in vitro transcribed hTR and [35S]cysteine-labelled FLAG-hTERT WT, Q169A, Q169D, or Q169N was incubated with 500 ng/mL chymotrypsin at 30degreesC for 30 s, 1 min, 2 min, 5 min, 10 min, 15 min, 30 min, and 45 min. 15 microL proteolysis reactions contained approximately equivalent counts of [35S]cysteine-labelled hTERT. Reactions were terminated by the addition of SDS-PAGE loading buffer and boiling (5 min). Following digestion, products were resolved by 12% SDS-PAGE and visualized by autoradiography and phosphorimaging. Arrows indicate the proteolytic fragments that are reduced upon substitution of hTERT Q169.
###end p 110
###begin p 111
(1.31 MB TIF)
###end p 111
###begin p 112
Click here for additional data file.
###end p 112
###begin p 113
Time-course proteolytic digestion of 1-300 hTERT WT and Q169 mutants. RRL containing A, [35S]cysteine-labelled 1-300 FLAG-hTERT WT, Q169A, Q169D, or Q169N or B, in vitro transcribed hTR and [35S]cysteine-labelled 1-300 FLAG-hTERT WT, Q169A, Q169D, or Q169N as incubated at 30degreesC with 500 ng/mL chymotrypsin for the indicated time (30 s, 1 min, 2 min, 5 min, 10 min, 15 min, 30 min, and 45 min), terminated by the addition of SDS-PAGE loading buffer and boiling (5 min), and resolved by 12% SDS-PAGE. 15 microL proteolysis reactions contained comparable counts of [35S]cysteine-labelled hTERT. Following digestion, products were resolved by 12% SDS-PAGE and visualized by autoradiography and phosphorimaging. Arrows indicate the proteolytic fragments that are reduced upon substitution of Q169 in 1-300 hTERT.
###end p 113
###begin p 114
(1.05 MB TIF)
###end p 114
###begin p 115
Click here for additional data file.
###end p 115
###begin p 116
We thank Dr. Steven Artandi for hTERT antibodies, Dr. Jan Karlseder for the telomeric probe, Dr. George Chaconas, Dr. Susan Lees-Miller, Dr. Karl Riabowol, and members of the Beattie lab for helpful discussions and technical assistance.
###end p 116
###begin title 117
References
###end title 117
###begin article-title 118
Telomeres, chromosome instability and cancer.
###end article-title 118
###begin article-title 119
How Shelterin Protects Mammalian Telomeres.
###end article-title 119
###begin article-title 120
###xml 21 26 <span type="species:ncbi:9606">human</span>
Telomeres: cancer to human aging.
###end article-title 120
###begin article-title 121
[Principle of marginotomy in template synthesis of polynucleotides].
###end article-title 121
###begin article-title 122
Origin of concatemeric T7 DNA.
###end article-title 122
###begin article-title 123
A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon.
###end article-title 123
###begin article-title 124
###xml 35 40 <span type="species:ncbi:9606">human</span>
Telomeres shorten during ageing of human fibroblasts.
###end article-title 124
###begin article-title 125
Identification of a specific telomere terminal transferase activity in Tetrahymena extracts.
###end article-title 125
###begin article-title 126
The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity.
###end article-title 126
###begin article-title 127
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis.
###end article-title 127
###begin article-title 128
The Structure and Function of Telomerase Reverse Transcriptase.
###end article-title 128
###begin article-title 129
Structure and function of telomerase RNA.
###end article-title 129
###begin article-title 130
Telomerase: biochemical considerations for enzyme and substrate.
###end article-title 130
###begin article-title 131
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human diseases of telomerase dysfunction: insights into tissue aging.
###end article-title 131
###begin article-title 132
###xml 18 23 <span type="species:ncbi:9606">human</span>
Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT.
###end article-title 132
###begin article-title 133
###xml 18 23 <span type="species:ncbi:9606">human</span>
Reconstitution of human telomerase activity in vitro.
###end article-title 133
###begin article-title 134
Functional requirement of p23 and Hsp90 in telomerase complexes.
###end article-title 134
###begin article-title 135
###xml 64 69 <span type="species:ncbi:9606">human</span>
Stable association of hsp90 and p23, but Not hsp70, with active human telomerase.
###end article-title 135
###begin article-title 136
###xml 44 49 <span type="species:ncbi:9606">human</span>
Protein composition of catalytically active human telomerase from immortal cells.
###end article-title 136
###begin article-title 137
Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly.
###end article-title 137
###begin article-title 138
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis.
###end article-title 138
###begin article-title 139
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats.
###end article-title 139
###begin article-title 140
Telomerase is processive.
###end article-title 140
###begin article-title 141
Telomerase primer specificity and chromosome healing.
###end article-title 141
###begin article-title 142
###xml 82 87 <span type="species:ncbi:9606">human</span>
Recognition of a chromosome truncation site associated with alpha-thalassaemia by human telomerase.
###end article-title 142
###begin article-title 143
Tetrahymena telomerase catalyzes nucleolytic cleavage and nonprocessive elongation.
###end article-title 143
###begin article-title 144
Sequence-specific DNA primer effects on telomerase polymerization activity.
###end article-title 144
###begin article-title 145
###xml 72 77 <span type="species:ncbi:9606">human</span>
Characterization of physical and functional anchor site interactions in human telomerase.
###end article-title 145
###begin article-title 146
Multiple DNA-binding sites in Tetrahymena telomerase.
###end article-title 146
###begin article-title 147
High-resolution physical and functional mapping of the template adjacent DNA binding site in catalytically active telomerase.
###end article-title 147
###begin article-title 148
###xml 72 77 <span type="species:ncbi:4932">yeast</span>
Modeling and structure function analysis of the putative anchor site of yeast telomerase.
###end article-title 148
###begin article-title 149
Mutation in TERT separates processivity from anchor-site function.
###end article-title 149
###begin article-title 150
Crystal structure of the essential N-terminal domain of telomerase reverse transcriptase.
###end article-title 150
###begin article-title 151
###xml 30 35 <span type="species:ncbi:9606">human</span>
Polymerization defects within human telomerase are distinct from telomerase RNA and TEP1 binding.
###end article-title 151
###begin article-title 152
###xml 30 35 <span type="species:ncbi:9606">human</span>
Functional multimerization of human telomerase requires an RNA interaction domain in the N terminus of the catalytic subunit.
###end article-title 152
###begin article-title 153
###xml 24 29 <span type="species:ncbi:9606">human</span>
Specific association of human telomerase activity with immortal cells and cancer.
###end article-title 153
###begin article-title 154
Requirements for the dGTP-dependent repeat addition processivity of recombinant Tetrahymena telomerase.
###end article-title 154
###begin article-title 155
###xml 22 27 <span type="species:ncbi:9606">human</span>
The C terminus of the human telomerase reverse transcriptase is a determinant of enzyme processivity.
###end article-title 155
###begin article-title 156
Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP).
###end article-title 156
###begin article-title 157
###xml 34 39 <span type="species:ncbi:9606">human</span>
Functional multimerization of the human telomerase reverse transcriptase.
###end article-title 157
###begin article-title 158
###xml 46 51 <span type="species:ncbi:9606">human</span>
Inhibition of telomerase limits the growth of human cancer cells.
###end article-title 158
###begin article-title 159
###xml 58 63 <span type="species:ncbi:9606">human</span>
Telomere shortening and apoptosis in telomerase-inhibited human tumor cells.
###end article-title 159
###begin article-title 160
###xml 38 43 <span type="species:ncbi:9606">human</span>
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
###end article-title 160
###begin article-title 161
###xml 21 26 <span type="species:ncbi:4932">yeast</span>
N-terminal domain of yeast telomerase reverse transcriptase: recruitment of Est3p to the telomerase complex.
###end article-title 161
###begin article-title 162
Sequencing of Saccharomyces telomeres cloned using T4 DNA polymerase reveals two domains.
###end article-title 162
###begin article-title 163
###xml 94 99 <span type="species:ncbi:9606">human</span>
Functional organization of repeat addition processivity and DNA synthesis determinants in the human telomerase multimer.
###end article-title 163
###begin article-title 164
Structure of the RNA-binding domain of telomerase: implications for RNA recognition and binding.
###end article-title 164
###begin article-title 165
Multisubunit RNA polymerases.
###end article-title 165
###begin article-title 166
RNA polymerase II structure: from core to functional complexes.
###end article-title 166
###begin p 167
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 167
###begin p 168
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was funded by a grant from the Alberta Cancer Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 168

